Additionally, reduced STMN2 expression has more recently been reported in the brain of patients with Parkinson’s disease (Wang et al., 2019), and frontotemporal dementia (Prudencio et al., 2020). The gene discussed is STMN2; the disease is frontotemporal dementia.